Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence

The role of genetic testing in the treatment decision-making process

Date

22 Sep 2020

Session

GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence

Presenters

Kathleen Moore

Authors

K.N. Moore

Author affiliations

  • Department Of Obstetrics And Gynecology University, Stephenson Cancer Center/University of Oklahoma, 73104 - Oklahoma City/US
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings